Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial
Douglass A. Morrison, MD, FACC,
Gulshan Sethi, MD, FACC,
Jerome Sacks, PhD,
William Henderson, PhD,
Frederick Grover, MD, FACC,
Steven Sedlis, MD, FACC,
Rick Esposito, MD,
Kodangudi Ramanathan, MD, FACC,
Darryl Weiman, MD,
Jorge Saucedo, MD,
Tamim Antakli, MD,
Venki Paramesh, MD,
Stuart Pett, MD,
Sarah Vernon, MD, FACC,
Vladimir Birjiniuk, MD,
Frederick Welt, MD,
Mitchell Krucoff, MD, FACC,
Walter Wolfe, MD, FACC,
John C. Lucke, MD,
Sundeep Mediratta, MD,
David Booth, MD, FACC,
Charles Barbiere, CCRN,
Daniel Lewis, MD, FACC for the Investigators of the Department of Veterans Affairs Cooperative Study 385 the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)

View larger version (19K):
[in a new window]
|
Figure 1 Kaplan-Meier survival plot of coronary artery bypass graft surgery (CABG) (circles) versus percutaneous coronary intervention (PCI) (squares). The CABG and PCI number of patients (N) and the percentage surviving for each time period are shown at the bottom of the plot.
|
|

View larger version (20K):
[in a new window]
|
Figure 2 Kaplan-Meier plot of survival free of unstable angina for coronary artery bypass graft surgery (CABG) (circles) versus percutaneous coronary intervention (PCI) (squares). The CABG and PCI number of patients (N) and the percentage surviving free of unstable angina for each time period are shown at the bottom of the plot.
|
|

View larger version (20K):
[in a new window]
|
Figure 3 Kaplan-Meier plot of survival free of unstable angina (UA) or repeat revascularization for coronary artery bypass graft surgery (CABG) (circles) versus percutaneous coronary intervention (PCI) (squares). The CABG and PCI number of patients (N) and the percentage surviving free of UA or repeat revascularizations for each time period are shown at the bottom of the plot.
|
|
|